Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210036844 210011639 1.79 29 Disease modification (D) 2018-07-11 2018-07-11 Chlorambucil N N 210030435 CHLORAMBUCIL
210036845 210011726 1.61 null Curative (C) 2017-01-05 2017-07-14 ALL Int Guide A/B/C Maint Ph V 2 null 210031008 ALL INTERIM GUIDELINES
210036846 210011734 null 90 Curative (C) 2016-11-17 2017-09-22 Chlorambucil N N 210031025 CHLORAMBUCIL
210036847 210011767 1.78 19.2 Curative (C) 2016-05-18 2016-05-31 Chlorambucil N N 210031164 CHLORAMBUCIL
210036848 210027514 0 19.5 Curative (C) 2018-06-02 2018-06-02 MERCAPTOPURINE + METHOTREXATE 99 null 210031465 MERCAPTOPURINE + METHOTREXATE
210036849 210011826 1.86 70 Disease modification (D) 2018-07-23 2018-07-31 CHOP R - 21 days Y N 210031507 CHOP R
210036851 210021565 1.87 82 Curative (C) 2019-06-19 2019-06-21 CHLORAMBUCIL + prednisolone 01 N 210031749 CHLORAMBUCIL
210036852 210011890 1.9 10.7 Disease modification (D) 2016-12-19 2016-12-19 ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) N N 210031811 UKALLR3
210036853 210011922 1.72 55.6 Curative (C) 2016-08-04 2017-04-16 Alemtuz+Fludara+Melphalan RIC MUD N N 210032019 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
210036854 210011927 null 72 Curative (C) 2014-03-10 2014-03-18 Alemtuzumab(INTRAVENOUS) N N 210032021 ALEMTUZUMAB
210036856 210012011 null 82 Curative (C) 2017-06-24 2017-06-25 Mercaptopurine N N 210032638 MERCAPTOPURINE
210036857 210012019 1.77 15.3 Curative (C) 2013-06-04 2015-02-25 ALL Int Guide A/B/C Maint Ph V N N 210032683 ALL INTERIM GUIDELINES
210036858 210012092 1.52 100.5 Disease modification (D) 2019-10-09 2019-10-17 Alemtuz+Fludara+Melphalan RIC MUD N null 210032998 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
210036859 210012141 1.87 65 Curative (C) 2014-08-31 2014-10-12 MERCAPTOPURINE + METHOTREXATE N N 210033299 MERCAPTOPURINE + METHOTREXATE
210036860 210012156 1.76 20.7 Palliative (P) 2016-06-07 2016-06-07 ALL ALLR3 FLAD Phase IV N null 210033375 UKALLR3
210036861 210012194 1.66 null null 2018-11-11 2018-11-11 ALEMTUZUMAB + FLUDARABINE + MELPHALAN null null 210033503 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
210036862 210021758 1.8 100.5 Curative (C) 2018-10-10 2018-10-10 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 210033652 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
210036863 210012240 1.73 49.5 Curative (C) null 2016-02-24 ALL Int Guide A/B/C Maint Ph V N N 210033764 ALL INTERIM GUIDELINES
210036864 210012254 null 78.6 Curative (C) 2016-06-06 2016-08-18 ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) 02 N 210033792 UKALLR3
210036865 210021790 1.7 101.3 Palliative (P) 2018-07-17 2018-07-17 CARBOPLATIN + ETOPOSIDE N N 210033859 BENDAMUSTINE
210036866 210021792 1.45 76.5 Not known (9) 2016-07-26 2016-07-26 PONATINIB N null 210033868 METHOTREXATE HIGH DOSE
210036867 210012279 null 83.9 Radical (R) 2013-06-06 2013-11-20 Pentostatin Y N 210033900 CYCLOPHOSPHAMIDE + VINCRISTINE
210036868 210012293 1.67 55.6 Curative (C) 2020-01-20 2020-01-20 Dasatinib Y N 210033985 DASATINIB
210036869 210021807 null null Curative (C) 2019-03-02 2019-05-04 LOMUSTINE + PROCARBAZINE Y N 210034017 LOMUSTINE + PROCARBAZINE
210036870 210012302 1.56 14.3 Curative (C) 2017-12-29 2018-01-04 Cyclophosphamide+Fludara+TBI Allo 2 N 210034037 CYCLOPHOSPHAMIDE + FLUDARABINE
210036871 210012319 1.85 null Palliative (P) 2017-07-10 2018-01-24 Dasatinib 02 N 210034115 DASATINIB
210036872 210027704 1.74 80.3 Curative (C) 2020-05-16 2020-09-02 RIALTO TRIAL N N 210034173 METHOTREXATE HIGH DOSE
210036873 210012342 null 80.3 Curative (C) 2018-08-27 2019-03-21 IDELALISIB Y N 210034234 INOTUZUMAB OZOGAMICIN
210036874 210012351 1.89 68.6 Curative (C) 2018-03-07 2018-03-21 Erwinase (Erwinia Asparaginase) N N 210034345 METHOTREXATE HIGH DOSE
210036875 210012353 1.7 75 Curative (C) 2017-10-16 2017-12-25 Bevacizumab 10mg/kg N N 210034354 PENTOSTATIN
210036876 210012374 1.55 53.2 Disease modification (D) 2017-04-11 2017-05-08 LOMUSTINE + PROCARBAZINE null N 210034516 LOMUSTINE + PROCARBAZINE
210036877 210021855 1.71 87.9 Curative (C) 2017-01-22 2017-01-22 LOMUSTINE + PROCARBAZINE 02 N 210034567 LOMUSTINE + PROCARBAZINE
210036878 210012396 1.48 101.3 null 2019-11-07 2019-11-08 CYCLOPHOSPHAMIDE N N 210034702 CYCLOPHOSPHAMIDE
210036879 210027733 0 null Curative (C) 2018-05-14 2018-11-12 Dasatinib Y N 210034764 DASATINIB
210036880 210012415 1.72 24.4 Adjuvant (A) 2018-06-19 2018-06-19 Cyclophosphamide Fludarabine (Oral) 2 N 210034801 CYCLOPHOSPHAMIDE + FLUDARABINE
210036881 210021887 1.72 54.5 Palliative (P) 2017-07-12 2017-11-29 Methotrexate High Dose (3g/m2) N N 210034995 CHLORAMBUCIL + OFATUMUMAB
210036883 210021917 1.83 22 Adjuvant (A) 2019-01-31 2019-06-19 Dasatinib N N 210035459 DASATINIB
210036884 210012532 1.85 71.6 Curative (C) 2020-03-19 2020-03-22 Bendamustine +/- Prednisolone N N 210035764 METHOTREXATE HIGH DOSE
210036885 210012566 1.71 58.7 Curative (C) 2019-07-03 2019-11-28 Carboplatin + Etoposide iv&po N N 210035996 BENDAMUSTINE
210036886 210012570 1.6 70.6 Curative (C) 2017-09-01 2017-10-10 CARBOPLATIN + VINCRISTINE Y Y 210036039 CARBOPLATIN + VINCRISTINE
210036887 210012599 1.77 null Palliative (P) 2015-08-31 2016-05-27 IDELALISIB N N 210036356 BENDAMUSTINE
210036888 210021978 0 59.5 Curative (C) 2017-10-31 2017-10-31 UKALL XII Maintenance (3 months) Y N 210036393 RIALTO TRIAL
210036889 210012645 1.9 77 Palliative (P) 2019-05-11 2019-06-09 CARBOPLATIN + VINCRISTINE Y null 210036653 CARBOPLATIN + VINCRISTINE
210036890 210022021 1.83 97.5 Curative (C) 2016-08-28 2016-08-29 Dasatinib N N 210036863 DASATINIB
210036892 210012734 1.85 35 Disease modification (D) 2018-07-01 2018-07-07 RIALTO TRIAL N N 210037156 NELARABINE
210036893 210012765 1.76 22.9 Adjuvant (A) 2016-04-25 2019-06-15 Procarbazine 02 N 210037304 PROCARBAZINE
210036894 210022063 null null Palliative (P) 2019-08-31 2019-09-10 LOMUSTINE + PROCARBAZINE 2 N 210037339 LOMUSTINE + PROCARBAZINE
210036895 210022068 1.85 71.5 Adjuvant (A) 2014-07-10 2014-07-18 Lenalidomide 25mg (Cycle 1 to 25) 02 Y 210037370 CVP
210036896 210012824 null 67.8 Adjuvant (A) 2015-05-30 2015-06-04 RCEOP 2 N 210037525 AZACITIDINE
210036897 210012827 1.46 19.3 Curative (C) 2015-03-28 2015-04-24 Bevacizumab + LOMUSTINE N N 210037527 BEVACIZUMAB + TEMOZOLOMIDE